Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes
Year: 2018
Type: article
Abstract: OBJECTIVE: Appropriate glucose levels are essential for survival; thus, the detection and correction of low blood glucose is of paramount importance. Hypoglycemia prompts an integrated response involving reduction in insulin release and secretion of key counter-regulatory hormones glucagon and epinephrine that together promote endogenous glucose production to restore normoglycemia. However, specifically how this response is orchestrated remains to be fully clarified. The low affinity hexokinase glucokinase is found in glucose-sensing cells involved in glucose homeostasis including pancreatic β-cells and in certain brain areas. Here, we aimed to examine the role of glucokinase in triggering counter-regulatory hormonal responses to hypoglycemia, hypothesizing that reduced glucokinase activity would lead to increased and/or earlier triggering of responses. METHODS: Hyperinsulinemic glucose clamps were performed to examine counter-regulatory responses to controlled hypoglycemic challenges created in humans with monogenic diabetes resulting from heterozygous glucokinase mutations (GCK-MODY). To examine the relative importance of glucokinase in different sensing areas, we then examined responses to clamped hypoglycemia in mice with molecularly defined disruption of whole body and/or brain glucokinase. RESULTS: GCK-MODY patients displayed increased and earlier glucagon responses during hypoglycemia compared with a group of glycemia-matched patients with type 2 diabetes. Consistent with this, glucagon responses to hypoglycemia were also increased in I366F mice with mutated glucokinase and in streptozotocin-treated β-cell ablated diabetic I366F mice. Glucagon responses were normal in conditional brain glucokinase-knockout mice, suggesting that glucagon release during hypoglycemia is controlled by glucokinase-mediated glucose sensing outside the brain but not in β-cells. For epinephrine, we found increased responses in GCK-MODY patients, in β-cell ablated diabetic I366F mice and in conditional (nestin lineage) brain glucokinase-knockout mice, supporting a role for brain glucokinase in triggering epinephrine release. CONCLUSIONS: Our data suggest that glucokinase in brain and other non β-cell peripheral hypoglycemia sensors is important in glucose homeostasis, allowing the body to detect and respond to a falling blood glucose.
Source: Molecular Metabolism
Institutions: University of Exeter, University of Cambridge, Wellcome/MRC Institute of Metabolic Science, Wellcome Trust, Mary Lyon Centre at MRC Harwell, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham Biomedical Research Centre, King's College London, University of Aberdeen
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,760
Funders: Juvenile Diabetes Research Foundation United Kingdom, Wellcome Trust, National Institute for Health and Care Research, Sir Jules Thorn Charitable Trust, Diabetes UK, Research Councils UK, University of Cambridge, Juvenile Diabetes Research Foundation Australia, Chang Gung University, Cambridge University Hospitals, Research and Development Corporation of Newfoundland and Labrador, Chang Gung Medical Foundation, Behavioural and Cognitive Neuroscience Institute, Simon Fraser University, Medical Research Council, Biotechnology and Biological Sciences Research Council, NIHR Exeter Clinical Research Facility
Awards: G1053271375, G1292542547, Function of brainstem brain-derived neurotrophic factor (Bdnf) in food choice, Brain Glucokinase and Blood Glucose: A Novel Therapeutic Target for Type 2 Diabetes?, New insights from Neonatal Diabetes., Metabolic consequence of in vivo modulation of discrete serotonergic pathways., Institute of Metabolic Science., G5761702259, G6323642449, G6387098835, NIHR Senior Investigator Award, G7021103344, NIHR Senior Investigator Award, Investigating changes in hypothalamic gene expression that underpins the loss of counter regulatory defences to hypoglycaemia., G8340673789, G8458495882, Behavioural and Clinical Neuroscience Institute (BCNI)
OpenAlex ID: W2887896850
